Welcome to our dedicated page for SELECT MEDICAL HOLDINGS SEC filings (Ticker: SEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Select Medical Holdings Corporation SEC filings document the formal disclosures of a NYSE-listed healthcare services company with common stock traded under SEM. Its Form 8-K reports cover operating results and financial condition, material-event disclosures, capital-structure information, employment and compensation-related agreements, and Regulation FD communications.
Proxy materials and annual-meeting filings describe director elections, executive compensation votes, auditor ratification, board-structure proposals, stockholder meeting rights and voting outcomes. The filings also record governance matters and corporate reporting related to Select Medical's hospital and outpatient rehabilitation operations.
Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of Select Medical Holdings Corporation common stock on an amended Schedule 13G. The reporting persons disclose beneficial ownership of 10,744,069 shares of common stock, representing 8.67% of the outstanding class.
They report 0 shares with sole voting or dispositive power and 10,744,069 shares with shared voting and shared dispositive power, held by funds and managed accounts for which Glazer Capital serves as investment manager. Mr. Glazer is managing member of Glazer Capital, and the filers state that the filing should not be construed as an admission of beneficial ownership under Section 13.
Vanguard Portfolio Management LLC filed Amendment No. 1 to a Schedule 13G reporting its beneficial ownership of common stock of Select Medical Holdings Corp. Vanguard reports beneficial ownership of 2,134 shares of common stock, representing 0% of the outstanding class, with sole dispositive power over all reported shares and no voting power.
The filing explains that the reported position reflects securities beneficially owned, or deemed beneficially owned, by Vanguard Portfolio Management LLC together with certain affiliates and business divisions, including Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. Vanguard states that various Vanguard investment companies and other managed accounts have the right to receive dividends or sale proceeds, and that no other single person’s interest relates to more than 5% of the class.
BlackRock, Inc. reports its beneficial ownership of common stock of Select Medical Holdings Corp. (SEM) in an amended Schedule 13G filing. BlackRock and certain of its business units beneficially own 12,320,106 shares of SEM common stock, representing 9.9% of the outstanding class.
BlackRock has sole voting power over 12,150,652 shares and sole dispositive power over all 12,320,106 shares, with no shared voting or dispositive power. The filing notes that at least one underlying fund, iShares Core S&P Small-Cap ETF, holds an interest in SEM common stock representing more than five percent of SEM’s total outstanding common stock.
Select Medical Holdings director Thomas Scully disposed of his remaining shares as part of a cash merger. The Form 4 shows a disposition of 103,424 shares of common stock to the issuer at $16.50 per share, leaving him with zero shares directly held after the transaction.
According to the merger agreement, each share of common stock, including unvested restricted shares that vested immediately before closing, was converted into the right to receive $16.50 in cash, less applicable tax withholdings. This reflects the automatic cash-out of his equity in connection with the completed merger.
Select Medical Holdings Corp director Katherine R. Davisson disposed of 60,035 shares of common stock at $16.50 per share in connection with a merger. Under the merger agreement, each of her shares, including previously unvested restricted shares that vested immediately before closing, was converted into the right to receive cash, leaving her with no remaining shares.
Select Medical Holdings director William H. Frist disposed of 306,266 shares of common stock in connection with the company’s merger. Each share was converted into the right to receive $16.50 in cash, and his direct common stock holdings fell to zero shares.
The transaction also covered unvested restricted shares, which fully vested immediately before the merger and were converted into the same cash consideration, subject to tax withholding.
SELECT MEDICAL HOLDINGS CORP director Marilyn B. Tavenner disposed of 36,035 shares of common stock in connection with a cash merger. Each share, including previously unvested restricted shares that vested immediately before closing, was converted into the right to receive $16.50 in cash. Following this merger-related conversion, she holds no shares directly.
Select Medical Holdings Corp director Thomas Daniel disposed of his remaining common stock in connection with the company’s merger. On the merger’s effective date, 80,035 shares of common stock were surrendered to the issuer at $16.50 per share, leaving him with no shares reported after the transaction.
Under the Agreement and Plan of Merger, each of his outstanding shares, including previously unvested restricted shares that fully vested immediately before closing, was converted into the right to receive cash merger consideration of $16.50 per share, less applicable tax withholdings.
Khanuja Parvinderjit S. reported disposition transactions in this Form 4 filing.
SELECT MEDICAL HOLDINGS CORP director Parvinderjit S. Khanuja had all of his common shares cashed out in a merger-related transaction. A total of 79,124 shares of common stock, including previously unvested restricted shares, were converted into the right to receive $16.50 per share in cash at the merger effective time, leaving him with no remaining shares.